Studies highlight the dual role of TMAO in the pathogenesis of cardiovascular diseases
In their latest publication researchers at the Laboratory of Pharmaceutical Pharmacology (LIOS) have demonstrated that microbiota-derived metabolite trimethylamine N-oxide (TMAO) protects mitochondrial energy metabolism and cardiac